FDA admits heart risk from Pfizer for males under 40

The FDA said more study is needed on the biggest risk highlighted by them to date of the Pfizer BioNTech Covid-19 vaccine, the only shot approved by them to date. Some males under 40 have been experiencing myocarditis and pericarditis, and even been hospitalized in critical care, according to the agency. But at this early stage in the vaccine effectiveness trials, they say more study is needed to determine how big of a risk the product really is to young men.

See the info contained on the FDA’s own website, and highlighted in the video below.